Loading…
INT Medical Instruments Co., Ltd. announced its intention to acquire at least a 51% stake in Hangzhou Weiqiang Medical Technology Co., Ltd. for a total of RMB 230 million, comprising an initial upfront payment of RMB 30 million and a capital investment of RMB 200 million.
Yingtai Medical (01501) announced on December 18, 2024, that it has signed an acquisition意向协议 to acquire at least a 51% controlling stake in Hangzhou Weiqiang Medical Technology through capital increase and share acquisition, with a planned capital increase of no less than RMB 200 million.